healthy adult
Conditions
Interventions
amino acid mixture, single dose
foods not containing amino acid mixture, single dose
Sponsors
KSO Corporation
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)(Healthy) males and females aged between 20 to 64 years old. (2)Subjects whose fasting blood glucose levels are from 100 mg/dL to 125 mg/dL, or OGTT test (after 2hours) blood glucose levels are from 140mg/dL to 199mg/dL. (3)Not heavy alcoholic drinker. (Subjects who can stop drinking from 2 days before each measurement.) (4) Subjects who can make self-judgment and are voluntarily giving written consent form.
Exclusion criteria
Exclusion criteria: (1)Subjects who use oral medication affecting blood glucose. (2)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting blood glucose. (3)Subjects who need medical treatment for diabetes. (4)Subjects who contract or are under treatment or are medical history for serious diseases (e.g.,liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder. (5)Subjects who have a operational history of digestive disease affecting digestion and absorption. (6)Subjects who are judged as unsuitable for the study based on the results of blood tests by the investigator at screening. (7)Subjects who have donated 400 mL of blood within 12 weeks prior to the start of the study and 200 mL of blood within 4 weeks and component blood donations (plasma component and platelet component blood donations) within 2 weeks prior to the start of the study. Also, considering the total amount of blood collected during the study, those who plan to donate blood within 12 weeks of the study. (8)Subjects who are diagnosed as anemic and not suitable for frequent collection of blood. (9)Subjects who developed diarrhea or took antibiotics within one week retroactive to the examination. (10)Subjects who are planning to participate in other clinical studies. (11)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating. (12)Subjects who are judged as unsuitable for the study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose levels | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma insulin levels | — |
Countries
Japan
Contacts
Public Contactkyoko miura
Ajinomoto Co., Inc. Healthcare Food Development Group Wellness Value Creation Center Institute of Food Sciences and Tech
Outcome results
None listed